实用肝脏病杂志 ›› 2026, Vol. 29 ›› Issue (5): 757-760.doi: 10.3969/j.issn.1672-5069.2026.05.030

• 胆石症 • 上一篇    下一篇

腹腔镜胆囊切除术治疗胆囊结石患者术中持续静脉输注艾司氯胺酮维持麻醉对术后疼痛和恢复质量的影响*

艾克拜尔·赛麦提, 努尔胡吉·麦麦提, 麦麦提依明·米吉提, 马依努尔·肉司坦   

  1. 844000 新疆维吾尔自治区喀什地区第一人民医院麻醉科(艾克拜尔·赛麦提,麦麦提依明·米吉提);肝胆胰腺外科(努尔胡吉·麦麦提);喀什大学附属第一医院麻醉科(马依努尔·肉司坦)
  • 收稿日期:2026-01-09 发布日期:2026-09-14
  • 通讯作者: 麦麦提依明·米吉提,E-mail:18509982599@163.com
  • 作者简介:艾克拜尔·赛麦提,男,41岁,大学本科,主治医师。E-mail:barquk007@163.com
  • 基金资助:
    新疆维吾尔自治区重大科技专项基金资助项目(编号:2020AB032)

Improvement of enhanced recovery after laparoscopic cholecystectomy by intraoperative infusion of esketamine in patients with gallstones

Aikbai'er Saimiti, Nurhujie Maimaiti, Maimaiti Yiming, et al   

  1. Department of Anesthesiology, First People's Hospital, Kashgar Region 844000,Xinjiang Uyghur Autonomous Region, China
  • Received:2026-01-09 Published:2026-09-14

摘要: 目的 观察腹腔镜胆囊切除术(LC)治疗胆囊结石患者术中持续静脉输注艾司氯胺酮维持麻醉对术后疼痛和恢复质量的影响。方法 2024年10月~2025年10月我院收治的98例胆囊结石患者,被随机分为两组(每组49例),均接受LC术治疗,在麻醉维持阶段,给予对照组生理盐水输注,给予观察组艾司氯胺酮静脉输注。采用疼痛视觉模拟量表(VAS)评估疼痛程度,采用15项恢复质量量表(QoR-15)评估恢复质量,采用ELISA法检测血清白介素-6(IL-6)、IL-8和肿瘤坏死因子(TNF-α)水平。结果 在术后1 h和12 h时,观察组静息VAS评分分别为(2.6±0.3)分和(2.7±0.4)分,均显著低于对照组【分别为(3.3±0.5)分和(3.4±0.3)分,P<0.05】,活动VAS评分分别为(2.9±0.3)分和(2.8±0.2)分,均显著低于对照组【分别为(3.6±0.4)分和(3.5±0.4)分,P<0.05】;在术后1 2 h和24 h时,观察组QoR-15评分分别为(114.3±10.2)分和(120.0±11.3)分,均显著大于对照组【分别为(101.6±7.1)分和(109.4±8.8)分,P<0.05】;在术后24 h时,观察组血清IL-6、IL-8和TNF-α水平分别为(82.3±9.7)pg/L、(51.3±9.0)pg/L和(16.5±1.9)pg/L,均显著低于对照组【分别为(105.8±10.5)pg/L、(83.7±11.3)pg/L和(22.8±2.3)pg/L,P<0.05】。结论 在LC术即将结束时,给予一次艾司氯胺酮静脉加强麻醉可能减轻胆囊结石患者术后疼痛,缓解细胞因子反应,加速康复。

关键词: 胆囊结石, 腹腔镜胆囊切除术, 麻醉, 艾司氯胺酮, 加速康复

Abstract: Objective The purpose of this study was to observe improvement of enhanced recovery after laparoscopic cholecystectomy (LC) by intraoperative infusion of esketamine in patients with gallstones. Methods A total of 98 patients with gallstones were encountered in our hospital between October 2024 and October 2025, randomly divided into two groups, and all underwent LC. At anesthesia maintaining stage, normal saline was given in control group, and intraoperative intravenous infusion of esketamine was given until discontinuation of surgery. Visual analog scale (VAS) was used to assess pain degree, and 15-item quality of recovery (QoR-15) scale was applied to evaluate recovery quality. Serum interleukin-6 (IL-6) , IL-8 and tumor necrosis factor-alpha (TNF-α) levels were measured by ELISA. Results By one hour and twelve hours after operation, resting VAS scores in the observation group were(2.6±0.3) and (2.7±0.4), both much lower than [(3.3±0.5) and (3.4±0.3), respectively, P<0.05],and motion VAS scores were (2.9±0.3) and (2.8±0.2), both much lower than [(3.6±0.4) and (3.5±0.4), respectively, P<0.05] in the control group; by twelve and twenty-fours, QoR-15 scores in the observation were (114.3±10.2) and (120.0±11.3), both significantly greater than [(101.6±7.1) and (109.4±8.8), respectively, P<0.05] in the control; by end of twenty-four after surgery, serum IL-6, IL-8 and TNF-α levels in the observation were (82.3±9.7)pg/L, (51.3±9.0)pg/L and (16.5±1.9)pg/L, all much lower than [(105.8±10.5)pg/L, (83.7±11.3)pg/L and (22.8±2.3)pg/L,respectively, P<0.05] in the control group. Conclusion Boosting intravenous infusion of esketamine once before discontinuation of LC could improve enhanced recovery after surgery (ERAS) in patients with gallstones, and warrants further clinical investigation.

Key words: Gallstone, Laparoscopic cholecystectomy, Esketamine, Anesthesia, Enhanced recovery after surgery